The SHARE study is an international multidisciplinary longitudinal survey. The panel survey has been conducted approximately every other year for over 20 years. In an analysis published in 2025, data from the ninth wave of the survey was analyzed to find out more about the prevalence of polypharmacy in different countries and to break down which factors are associated with it.
Autoren
- Mirjam Peter, M.Sc.
Publikation
- HAUSARZT PRAXIS
Related Topics
You May Also Like
- From symptom to diagnosis
Abdominal Pain – Von Meyenburg Complexes of the Liver
- Multiple sclerosis
Physical and psychosocial fatigue have the greatest impact on HRQoL
- Congenital Vascular Malformations
Personalized Treatment Before a Planned Pregnancy
- Hyperhidrosis: Keep a Cool Head
An Overview of Important Treatment Options
- This article was sponsored by Johnson & Johnson.
Give your patients a chance to live longer without progression with TECVAYLI® + DARZALEX® compared to DPd/DVd1
- Sjögren's Syndrome in Early Childhood
Children often develop lymphomas
- 2026 Vaccination Schedule: Important Changes
Updated Recommendations on Pneumococcal Disease and RSV
- Multidrug-Resistant Pathogens in Wound Care